Results 171 to 180 of about 6,262,677 (213)

Tolvaptan pharmacokinetics and pharmacodynamics in adolescents with autosomal dominant polycystic kidney disease. [PDF]

Eur J Pediatr
Shoaf SE, Sikes K.
europepmc   +1 more source

Refining Tolvaptan Dosing in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Kidney360
Dahl NK, Torres VE.
europepmc   +1 more source

Feasibility Study of Empagliflozin in Patients with Autosomal Dominant Polycystic Kidney Disease: Design and Baseline Characteristics. [PDF]

Am J Nephrol
Seliger SL, Wang W, Watnick T, George D, Diggs C, West M, Nowak K, Ostrow A, You Z, Gitomer B, Chonchol M.   +10 more
europepmc   +1 more source

Overweight and Obesity Are Associated with Lower Renal Blood Flow in Autosomal Dominant Polycystic Kidney Disease.

Kidney Blood Press Res
Birznieks CL, Wang W, Steele C, You Z, Gitomer B, Chonchol M, Nowak KL.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Autosomal Dominant Polycystic Kidney Disease

Primary Care: Clinics in Office Practice, 2020
Autosomal Dominant Polycystic Kidney Disease is an inherited multisystemic disorder of the renal tubules with subsequent formation of multiple cysts and enlargement of the kidney, affecting various organs. Diagnosis is initially suspected in those with family history and/or individuals who develop hypertension early on (secondary hypertension) or ...
Parvathi, Perumareddi, Darin P, Trelka
openaire   +2 more sources

Autosomal dominant polycystic kidney disease

The Lancet, 2019
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and one of the most common causes of end-stage kidney disease. Multiple clinical manifestations, such as enlarged kidneys filled with growing cysts, hypertension, and multiple extrarenal complications, including liver cysts, intracranial aneurysms, and ...
Emilie, Cornec-Le Gall, Ahsan, Alam, Ronald D, Perrone   +2 more
openaire   +2 more sources

Autosomal dominant polycystic kidney disease

Disease-a-Month, 2015
Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disease of the kidneys that can cause an irreversible decline in kidney function leading to end-stage renal disease. It is one of the most common hereditary disorders. It is 10 times more common than sickle cell disease and 20 times more common than Huntington's disease.
Jonathan, Silverman, Chaitanya, Desai, Edgar V, Lerma   +2 more
openaire   +2 more sources

Autosomal dominant polycystic kidney disease in the fetus

American Journal of Medical Genetics, 1994
AbstractWe report on 3 cases with a fetal presentation of autosomal dominant polycystic kidney disease (ADPKD), which illustrate the variable expression of ADPKD during fetal life. Fetus 1 was diagnosed at 20 weeks of gestation by ultrasonography; a molecular prenatal diagnosis was performed at 10 weeks on fetus 2, a sib of fetus 1; and ADPKD was an ...
J, Michaud, P, Russo, A, Grignon, L, Dallaire, D, Bichet, D, Rosenblatt, E, Lamothe, M, Lambert   +7 more
openaire   +2 more sources

Diagnosis of autosomal dominant polycystic kidney disease

Expert Opinion on Medical Diagnostics, 2008
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and accounts for 5 - 10% of end stage renal disease. Mutations of two genes, PKD1 and PKD2, account for ∼ 85 and ∼ 15% of cases, respectively.This paper reviews the clinical features of ADPKD, highlights the current roles for image- and molecular-based ...
York, Pei, Xiao, Zhao
openaire   +2 more sources